Authorizes $5.5 billion state bonds for: stem cell and other medical research, including training; research facility construction; administrative costs. Dedicates $1.5 billion to brain-related diseases. Appropriates General Fund moneys for repayment. Expands related programs. Fiscal Impact: Increased state costs to repay bonds estimated at about $260 million per year over the next roughly 30 years.
ANTONI RIBAS, M.D., Ph.D., President American Association for Cancer Research CYNTHIA E. MUÑOZ, Ph.D., MPH, President American Diabetes Association–Los Angeles ROBERT A. HARRINGTON, M.D., Chairman Department of Medicine, Stanford University
VINCENT FORTANASCE, M.D. PATRICK JAMES BAGGOT, M.D.
Rebuttal Against Author
TODD SHERER, Ph.D., CEO The Michael J. Fox Foundation for Parkinson’s Research LAWRENCE GOLDSTEIN, Ph.D., Distinguished Professor Shiley–Marcos Alzheimer’s Disease Research Center, University of California, San Diego TRACY GRIKSCHEIT, M.D., Chief of Pediatric Surgery Children's Hospital Los Angeles
AUTHORIZES BONDS TO CONTINUE FUNDING STEM CELL AND OTHER MEDICAL RESEARCH. INITIATIVE STATUTE California Proposition 14 (2020).